Lymphedema and Axillary-Lateral Thoracic Vessel Juncture Irradiation: A Clinical Dilemma
There is insufficient data to define ALTJ as an OAR for decreasing BCRL risk. It is not appropriate to define dose and target based on ALTJ. Prospective studies with larger patient populations are needed to clarify the relationship between ALTJ and lymphedema.
Authors
- Duygu Sezen (ORCID: https://orcid.org/0000-0002-4505-2280)
- Nilüfer Kılıç Durankuş (ORCID: https://orcid.org/0000-0001-9255-8340)
- Şükran Şenyürek (ORCID: https://orcid.org/0000-0003-3010-6132)
- Yasemin Bölükbaşı (ORCID: https://orcid.org/0000-0002-3170-5826)
- Mustafa Duman (ORCID: https://orcid.org/0000-0002-0276-0543)
- Salih Zeki Güçlü (ORCID: https://orcid.org/0009-0003-7496-104X)
Institutions
- Koç University (TR)
Publication Details
- Journal
- European Journal of Breast Health
- Published
- 2025-08-04
- DOI
- https://doi.org/10.4274/ejbh.galenos.2025.2025-2-8
- Primary Topic
- Lymphatic System and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00